Skip to Content

  • Search

Abington Jefferson

Jefferson and Abington Now One

Jefferson and Abington Health today announced their “hub and hub” merger has been completed, marking a new era in urban/suburban access to some of the nation’s finest clinicians, scientists, academicians and healthcare professionals. The newly formed organization, to be known as Jefferson, will encompass Thomas Jefferson University plus Jefferson Health, the new combined clinical brand. - Read More

Top Docs 2015

Congratulations to Our 2015 TOP DOCS

We’re proud to acknowledge our Abington – Jefferson Health physicians on Philadelphia Magazine’s "Top Doc" list for 2015, which includes physicians from Abington Hospital and Abington Lansdale Hospital. – Read More

Health Grades Patient Awards 2015

Lansdale Hospital Recognized by Healthgrades® for Achievements in Patient Safety and Patient Experience

Lansdale Hospital announced today that it has achieved two distinctions of quality excellence from Healthgrades: the Healthgrades 2015 Patient Safety Excellence Award™ and the Healthgrades 2015 Outstanding Patient Experience Award™. Healthgrades is the leading online resource for comprehensive information about hospitals and physicians. – Read More

Get With The Guidelines® - Stroke Gold Plus award

Abington’s Diamond Stroke Center Recognized by the AHA/ASA

We are proud to announce that Abington Memorial Hospital has been approved for the Get With The Guidelines® – Stroke Gold Plus award. The stroke center has also qualified for recognition on the Target: Stroke Honor Roll-Elite. Abington’s center is part of an elite group of hospitals recognized by the American Heart Association/American Stroke Association. – Read More

Hana Choe, MD

Abington Participates in Trial Showing Clot Retrieval Improves Outcomes, Reduces Death in Stroke Patients

Researchers have completed an international randomized controlled trial showing that a clot retrieval procedure, known as endovascular treatment (ET), can dramatically improve patient outcomes after an acute ischemic stroke. Abington Health’s Neurosciences Institute is one of 22 sites worldwide that enrolled patients in the trial. – Read More